Editor’s Commentary: A Time for Refection and Anticipation J. Rick Turner Commentary 01 November 2011 Pages: 687 - 689
Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk-Beneft Assessment John J. Doyle Commentary 01 November 2011 Pages: 691 - 696
Associate Editor’s Commentary: The Danger of Shorting Drug Shortages Peter J. Pitts Commentary 01 November 2011 Pages: 697 - 698
Fewer Drugs, Shorter Lives, Less Prosperity: The Impact of Comparative Effectiveness Research on Health and Wealth John VernonRobert GoldbergJoseph H. Golec Commentary 01 November 2011 Pages: 699 - 703
Letter to the Editor Joanne ZhangNorman Stockbridge Letter to the Editor 01 November 2011 Pages: 713 - 715
Ten-year Experience of the Evaluation of Ethnic Sensitivity Data Chia-Ling HsiaoYeong-Liang LinKuang-Yang Hsu Clinical Trials 01 November 2011 Pages: 717 - 724
Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies Zheng Su Clinical Trials 01 November 2011 Pages: 725 - 729
Platelet Aggregation Quality Control in a Multicenter, Phase 2 Clinical Trial James McRedmond Clinical Trials 01 November 2011 Pages: 731 - 740
A Longitudinal Model and Graphic for Beneft-risk Analysis, With Case Study Jonathan D. Norton Statistics 01 November 2011 Pages: 741 - 747
A benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making Andreas Sashegyi Statistics 01 November 2011 Pages: 749 - 757
Validation of Decision-enabling Tools: Showing That the Model Is Useful Niclas SjögrenStig Johan Wiklund Statistics 01 November 2011 Pages: 759 - 765
Evaluation of Drug Adverse Event Intake and Reporting in a Medical Information Service Pamela D. AllenRobert J. FuentesGreg Susla Drug Information 01 November 2011 Pages: 767 - 773
Failure to Communicate: Medication Guide or Memory? Louis A. MorrisMorris S. WhitcupKeith LaMattina Drug Information 01 November 2011 Pages: 775 - 786
Content Analysis of Off-label Drug Use: Reporting Print Media Coverage Dipen A. PatelAvani D. JoshiKunal Saxena Drug Information 01 November 2011 Pages: 787 - 796
Assessment of Electronic Drug Information Resource Availability in Alabama Pharmacies Peter J. HughesMichael KendrachMaisha Kelly Freeman Drug Information 01 November 2011 Pages: 797 - 803
Clinically Important Effects in New Drug Development Kanae TogoNobushige MatsuokaTakashi Moriya Drug Information 01 November 2011 Pages: 805 - 810
Medical Information Services in the Age of Social Media and New Customer Channels Poonam BordoloiAndrew GažoLesley Fierro Drug Information 01 November 2011 Pages: 811 - 818
Certification for the Medical Science Liaison: An Idea Whose Time Has Come—or Not Jane ChinKenneth L. MasseyJimmy Black Drug Information 01 November 2011 Pages: 819 - 823
Review of: Fundamentals of US Regulatory Affairs, 7th ed. Edward Tabor Book Review 01 November 2011 Pages: 825 - 826